Lantern Pharma raises CSO Kishor Bhatia's base salary to $235,000 effective Jan 2023

Lantern Pharma Inc.

Board approved amendment to employment agreement increasing annual base salary to $235,000.
Increase takes effect with the first pay period in January 2023.
Dr. Bhatia continues as Chief Scientific Officer of Lantern Pharma.

item 5.02

Lantern Pharma Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-001789

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.